ProLung Featured in MedTech Strategist’s “Start-Ups to Watch”

April 02, 2018

ProLung is honored to be featured in a special issue of MedTech Strategist for innovative technologies and influential companies. As a “Start-Up to Watch”, ProLung CEO and co-founder, Steven C. Eror, shares the development behind ProLung’s solution to an unmet clinical need for lung cancer. Read full article: [Link to attached PDF]